Tempest Therapeutics Inc. buy BiotechBee
Start price
16.10.23
/
50%
€6.05
Target price
31.05.25
€12.00
Performance (%)
-44.66%
Price
09:26
€3.35
Summary
This prediction is currently active. Massive losses of -44.66% have been the result for the BUY prediction by BiotechBee. This prediction currently runs until 31.05.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Tempest Therapeutics Inc. | 13.246% | 13.246% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
According to BiotechBee what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Buy mit Kursziel 12,0